UnitedHealth Group Inc. UNH stock is trading lower on Thursday in reaction to a media report on a possible investigation for criminal Medicare fraud.

UnitedHealth: Should You Buy This Falling Knife?

11:29am, Thursday, 15'th May 2025
Despite massive recent weakness and uncertainty, I believe UNH is a "reluctant" buy due to its cash flow, dividend, and systemic importance. UNH faces unprecedented selling pressure, CEO resignation,
The Wall Street Journal on Wednesday cited people familiar with the matter as saying that the probe has been ongoing since last year.
Justice department investigation into health insurance giant reported as company's CEO says he will retire
UNH's troubles are piling up, from a fresh DOJ criminal probe and rising costs to leadership shakeups and pulled guidance.
In a market where healthcare stocks are facing their worst month in 24 years, Palantir Technologies Inc PLTR is stealing the spotlight, soaring over 32% in the past month and a staggering 500% over th

UNH Stock Vs. CVS Stock

11:00am, Thursday, 15'th May 2025
Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs. This comes during a challenging time when the
Shares of UnitedHealth Group plunged more than 18% following a report that the Department of Justice is carrying out a criminal investigation into the health-care giant over possible Medicare fraud. T
The Justice Department has had a probe into UnitedHealth Group's Medicare Advantage business since at least last summer, the Wall Street Journal reported, citing unidentified people familiar with the
The pressure mounts for UnitedHealth (UNH) as shares plummet following news of a DOJ probe into its Medicare Advantage program. Diane King Hall joins Caroline Woods at the NYSE set to dive into the re
Shares of UnitedHealth Group tumbled more than 15% in morning trade on Thursday after a report said that the Justice Department is investigating the health insurer for potential fraud.
UnitedHealth Group stock has plummeted since my last Buy rating and is ~55% off highs, but its lower valuation now offers a significant margin of safety, making it a Buy. Disappointing Q1-2025 results
UnitedHealth faces severe headwinds: CEO change, regulatory probes, cost overruns, and suspended guidance have driven a dramatic valuation reset. Despite the turmoil, UNH now trades at a deep discount

UnitedHealth: Sell-Off Has Gone Too Far

08:14am, Thursday, 15'th May 2025
UNH's stock plunge seems to be overdone, with current prices reflecting worst-case scenarios from potential DOJ probes and guidance cuts. Even if the probe comes, some historical market reactions to s
UnitedHealth is also dealing with government pressure on drug prices and a vow to “knock out” drug middlemen.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE